首页 > 最新文献

The Prescriber最新文献

英文 中文
Use of progestogen‐only pills for oral contraception 口服避孕药中仅使用孕激素药片
Pub Date : 2023-06-01 DOI: 10.1002/psb.2069
Jenny Kitson
The progestogen‐only pill (POP) is often a safe and effective option for women who prefer oral contraception but in whom combined hormonal contraception is unsuitable. This article outlines the choice of POPs available, their administration, efficacy and adverse effects.
对于喜欢口服避孕药但不适合联合激素避孕药的妇女,单孕激素避孕药(POP)通常是一种安全有效的选择。本文概述了现有持久性有机污染物的选择、施用、功效和不利影响。
{"title":"Use of progestogen‐only pills for oral contraception","authors":"Jenny Kitson","doi":"10.1002/psb.2069","DOIUrl":"https://doi.org/10.1002/psb.2069","url":null,"abstract":"The progestogen‐only pill (POP) is often a safe and effective option for women who prefer oral contraception but in whom combined hormonal contraception is unsuitable. This article outlines the choice of POPs available, their administration, efficacy and adverse effects.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"130 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81504678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current management of suspected sepsis in primary care 初级保健中疑似败血症的当前管理
Pub Date : 2023-06-01 DOI: 10.1002/psb.2073
Marco Motta, M. Wilcock, W. Howe, R. Sheehan
Recognition and early treatment of sepsis are important to optimise patient outcomes, but this is an area that many general practices currently find challenging. Here, the authors discuss the findings of their short survey of GP practices in Cornwall to determine current approaches to the management of suspected sepsis in primary care and to identify areas for improvement.
识别和早期治疗败血症对于优化患者预后非常重要,但这是许多全科医生目前发现具有挑战性的领域。在这里,作者讨论了他们对康沃尔全科医生实践的简短调查结果,以确定目前在初级保健中管理疑似败血症的方法,并确定需要改进的领域。
{"title":"Current management of suspected sepsis in primary care","authors":"Marco Motta, M. Wilcock, W. Howe, R. Sheehan","doi":"10.1002/psb.2073","DOIUrl":"https://doi.org/10.1002/psb.2073","url":null,"abstract":"Recognition and early treatment of sepsis are important to optimise patient outcomes, but this is an area that many general practices currently find challenging. Here, the authors discuss the findings of their short survey of GP practices in Cornwall to determine current approaches to the management of suspected sepsis in primary care and to identify areas for improvement.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"141 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74294766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Population growth: one less thing to bother us? 人口增长:少了一件困扰我们的事?
Pub Date : 2023-06-01 DOI: 10.1002/psb.2074
Steve Head
As a baby boomer and retired doctor, are the things that bothered Steve Head in his youth – nuclear war, pollution and population growth – the same as the things that bother him now?
作为一名婴儿潮一代和退休医生,史蒂夫·海德年轻时困扰他的事情——核战争、污染和人口增长——和现在困扰他的事情一样吗?
{"title":"Population growth: one less thing to bother us?","authors":"Steve Head","doi":"10.1002/psb.2074","DOIUrl":"https://doi.org/10.1002/psb.2074","url":null,"abstract":"As a baby boomer and retired doctor, are the things that bothered Steve Head in his youth – nuclear war, pollution and population growth – the same as the things that bother him now?","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"67 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80283135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
BTS on community‐acquired and aspiration pneumonia BTS治疗社区获得性和吸入性肺炎
Pub Date : 2023-06-01 DOI: 10.1002/psb.2071
S. Chaplin
The British Thoracic Society (BTS) has recently published new Clinical Statements on community‐acquired pneumonia in people with learning disability and on aspiration pneumonia, offering best practice advice for managing these conditions. This article summarises some of the main clinical practice points from the statements.
英国胸科学会(BTS)最近发表了关于学习障碍患者社区获得性肺炎和吸入性肺炎的新临床声明,为管理这些疾病提供了最佳实践建议。本文从这些陈述中总结了一些主要的临床实践要点。
{"title":"BTS on community‐acquired and aspiration pneumonia","authors":"S. Chaplin","doi":"10.1002/psb.2071","DOIUrl":"https://doi.org/10.1002/psb.2071","url":null,"abstract":"The British Thoracic Society (BTS) has recently published new Clinical Statements on community‐acquired pneumonia in people with learning disability and on aspiration pneumonia, offering best practice advice for managing these conditions. This article summarises some of the main clinical practice points from the statements.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"67 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84420864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Realising the benefits of chronotherapy 意识到时间疗法的好处
Pub Date : 2023-06-01 DOI: 10.1002/psb.2067
{"title":"Realising the benefits of chronotherapy","authors":"","doi":"10.1002/psb.2067","DOIUrl":"https://doi.org/10.1002/psb.2067","url":null,"abstract":"","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77158971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Finerenone for chronic kidney disease in type 2 diabetes 芬尼酮治疗2型糖尿病慢性肾病
Pub Date : 2023-06-01 DOI: 10.1002/psb.2072
S. Chaplin
Finerenone (Kerendia) is a mineralocorticoid‐receptor antagonist for the treatment of chronic kidney disease in patients with type 2 diabetes. This article discusses its indications, efficacy and adverse effects.
Finerenone (Kerendia)是一种矿皮质激素受体拮抗剂,用于治疗2型糖尿病患者的慢性肾病。本文就其适应症、疗效及不良反应作一探讨。
{"title":"Finerenone for chronic kidney disease in type 2 diabetes","authors":"S. Chaplin","doi":"10.1002/psb.2072","DOIUrl":"https://doi.org/10.1002/psb.2072","url":null,"abstract":"Finerenone (Kerendia) is a mineralocorticoid‐receptor antagonist for the treatment of chronic kidney disease in patients with type 2 diabetes. This article discusses its indications, efficacy and adverse effects.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82366399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Semaglutide for weight management in adults 西马鲁肽用于成人体重管理
Pub Date : 2023-05-01 DOI: 10.1002/psb.2066
S. Chaplin
Semaglutide (Wegovy) is a GLP‐1 analogue indicated as an adjunct to diet and physical activity for weight management in adults who are overweight or obese. This article discusses its efficacy, adverse effects and place in therapy.
Semaglutide (Wegovy)是一种GLP‐1类似物,被认为是超重或肥胖成人体重管理的饮食和体育活动辅助药物。本文就其疗效、不良反应及在治疗中的地位作一探讨。
{"title":"Semaglutide for weight management in adults","authors":"S. Chaplin","doi":"10.1002/psb.2066","DOIUrl":"https://doi.org/10.1002/psb.2066","url":null,"abstract":"Semaglutide (Wegovy) is a GLP‐1 analogue indicated as an adjunct to diet and physical activity for weight management in adults who are overweight or obese. This article discusses its efficacy, adverse effects and place in therapy.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90083335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safe prescribing for refugees and asylum seekers 为难民和寻求庇护者提供安全处方
Pub Date : 2023-05-01 DOI: 10.1002/psb.2062
Sophie Rowlands
Prescribing safely for refugees and asylum seekers presents a unique set of challenges. This article discusses some of the issues that need to be addressed, including removing barriers to medicine access and ensuring continuity of care, and outlines the work of the Refugee and Asylum Seeker Service at the Alliance for Better Care.
为难民和寻求庇护者安全开药带来了一系列独特的挑战。本文讨论了需要解决的一些问题,包括消除获得药物的障碍和确保护理的连续性,并概述了改善护理联盟的难民和寻求庇护者服务的工作。
{"title":"Safe prescribing for refugees and asylum seekers","authors":"Sophie Rowlands","doi":"10.1002/psb.2062","DOIUrl":"https://doi.org/10.1002/psb.2062","url":null,"abstract":"Prescribing safely for refugees and asylum seekers presents a unique set of challenges. This article discusses some of the issues that need to be addressed, including removing barriers to medicine access and ensuring continuity of care, and outlines the work of the Refugee and Asylum Seeker Service at the Alliance for Better Care.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84858413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prescribing Skills Assessment 处方技能评估
Pub Date : 2023-05-01 DOI: 10.1002/psb.2060
{"title":"Prescribing Skills Assessment","authors":"","doi":"10.1002/psb.2060","DOIUrl":"https://doi.org/10.1002/psb.2060","url":null,"abstract":"","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"85 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79389333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Summary of new NICE quality standards for diabetes in adults 成人糖尿病NICE新质量标准综述
Pub Date : 2023-05-01 DOI: 10.1002/psb.2065
S. Chaplin
NICE has recently updated its quality standard statements for adults with diabetes, now dividing them into separate standards for type 1 and type 2 diabetes, with some shared features. This article discusses the main changes to the quality statements and the outcomes measured.
NICE最近更新了成人糖尿病患者的质量标准声明,现在将其分为1型和2型糖尿病的单独标准,并具有一些共同的特征。本文讨论了质量声明和测量结果的主要变化。
{"title":"Summary of new NICE quality standards for diabetes in adults","authors":"S. Chaplin","doi":"10.1002/psb.2065","DOIUrl":"https://doi.org/10.1002/psb.2065","url":null,"abstract":"NICE has recently updated its quality standard statements for adults with diabetes, now dividing them into separate standards for type 1 and type 2 diabetes, with some shared features. This article discusses the main changes to the quality statements and the outcomes measured.","PeriodicalId":88184,"journal":{"name":"The Prescriber","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84164665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Prescriber
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1